BioNexus Gene Lab (BGLC) Work In Process (2024 - 2025)
BioNexus Gene Lab's (BGLC) quarterly Work In Process came in at $190588.0 in Q3 2025, up 0.95% quarter-over-quarter from $188797.0 in Q4 2024.
Powered by 
Analysis
BioNexus Gene Lab (BGLC) Work In Process (2024 - 2025) Analysis & Trends
BioNexus Gene Lab has disclosed Work In Process across 2 years of filings, most recently posting $190588.0 for Q3 2025.
- In Q3 2025, Work In Process changed N/A year-over-year to $190588.0; the TTM figure through Sep 2025 stood at $190588.0 (changed N/A YoY), while the FY2024 annual figure was $188797.0, changed N/A from the prior year.
- Work In Process came in at $190588.0 for Q3 2025 at BioNexus Gene Lab, up from $188797.0 in the prior quarter.
- In the past five years, Work In Process ranged from a high of $190588.0 in Q3 2025 to a low of $188797.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | W.W. Grainger | 62.38 Bn | 62.17 Bn | 1.98 Bn |
| 2 | Fastenal | 56.92 Bn | 56.71 Bn | 1.06 Bn |
| 3 | Ferguson Enterprises | 44.34 Bn | 43.52 Bn | 2.32 Bn |
| 4 | Reliance | 20.45 Bn | 20.23 Bn | 1.30 Bn |
| 5 | Wesco International | 17.12 Bn | 16.31 Bn | 1.46 Bn |
| 6 | Applied Industrial Technologies | 11.98 Bn | 11.86 Bn | 411.22 Mn |
| 7 | Watsco | 11.22 Bn | 11.23 Bn | 578.93 Mn |
| 8 | Avantor | 10.13 Bn | 9.82 Bn | 537.00 Mn |
| 9 | Core & Main | 8.33 Bn | 8.25 Bn | 520.00 Mn |
| 10 | BioNexus Gene Lab | 2.60 Mn | -922,180.04 | 12,982.00 |